Clinical Trials Browser

INDUSTRY × Interventional × TVB-2640 × Clear all

NCT05118776 2024-10-31

Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM

Phase 3 Active not recruiting

Glioblastoma

NCT02223247 2017-08-14

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

Phase 1 Completed

Neoplasms